Miller AM, Shah RH, Pentsova EI, Pourmaleki M, Briggs S, Distefano N, Zheng Y, Skakodub A, Mehta SA, Campos C et al..
2019.
Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid.. Nature. 565(7741):654-658.
Ivanidze J, Lum M, Pisapia D, Magge R, Ramakrishna R, Kovanlikaya I, Fine HA, Chiang GC.
2019.
MRI Features Associated with TERT Promoter Mutation Status in Glioblastoma.. J Neuroimaging. 29(3):357-363.
Ramos AD, Magge RS, Ramakrishna R.
2018.
Molecular Pathogenesis and Emerging Treatment for Glioblastoma.. World Neurosurg. 116:495-504.
Omay SBulent, Chen Y-N, Almeida JPaulo, Ruiz-Treviño ASaul, Boockvar JA, Stieg PE, Greenfield JP, Souweidane MM, Kacker A, Pisapia DJ et al..
2018.
Do craniopharyngioma molecular signatures correlate with clinical characteristics? J Neurosurg. 128(5):1473-1478.